United States · FDA National Drug Code directory
Loratadine antihistamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66267-653_2b4e1a74-38aa-956a-e063-6294a90ae2f1
- Product NDC
- 66267-653
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20081015
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET in 1 BOTTLE (66267-653-07) · 66267-653-07
- 10 TABLET in 1 BOTTLE (66267-653-10) · 66267-653-10
- 14 TABLET in 1 BOTTLE (66267-653-14) · 66267-653-14
- 20 TABLET in 1 BOTTLE (66267-653-20) · 66267-653-20
- 30 TABLET in 1 BOTTLE (66267-653-30) · 66267-653-30
- 60 TABLET in 1 BOTTLE (66267-653-60) · 66267-653-60
- 90 TABLET in 1 BOTTLE (66267-653-90) · 66267-653-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →